Literature DB >> 2051579

[The hemodynamic and metabolic changes following tourniquet release during halothane anesthesia].

M Tsuchiya1, W Ueda, M Tomoda, Y Mokudai, A Takeda, M Hirakawa.   

Abstract

We measured the hemodynamic and metabolic changes following the release of lower limb tourniquet during halothane anesthesia, and discussed the cause of reduction in the blood pressure and the effective method for prevention. Cardiac index decreased transiently following the release, and gradually increased afterward. Systemic vascular resistance index decreased continuously and progressively until 10 minutes after the release. These results indicate that the causative factors of reduction in the blood pressure are temporary decrease in cardiac output and subsequent decrease in systemic vascular resistance. In mixed venous blood, pH decreased, PCO2 increased and HCO3- remained unchanged after the release. It seems that pH reduction was chiefly caused by the increase in PO2. Thus, the preventive method for reduction in the blood pressure following the tourniquet release may be as follows; 1) intravenous fluid loading, 2) hyperventilation, 3) elevation of lower limb, 4) lightning the anesthesia, and 5) finally giving vasopressors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051579

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  2 in total

1.  Differential effects of hyperventilation on cerebral blood flow velocity after tourniquet deflation during sevoflurane, isoflurane, or propofol anesthesia.

Authors:  Hiroshi Hinohara; Yuji Kadoi; Masanobu Ide; Masataka Kuroda; Shigeru Saito; Akio Mizutani
Journal:  J Anesth       Date:  2010-06-01       Impact factor: 2.078

2.  Time course of changes in cerebral blood flow velocity after tourniquet deflation in patients with diabetes mellitus or previous stroke under sevoflurane anesthesia.

Authors:  Hiroshi Hinohara; Yuji Kadoi; Kenichiro Takahashi; Shigeru Saito; Chikara Kawauchi; Akio Mizutani
Journal:  J Anesth       Date:  2011-04-07       Impact factor: 2.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.